| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | Certolizumab Ab | LP250850-7 |
| PROPERTY | ACnc | LP6773-8 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser/Plas | LP7576-4 |
| SCALE_TYP | Qn | LP7753-9 |
| METHOD_TYP | IA | LP217197-5 |
| parent | Certolizumab | Serum or Plasma | Drug toxicology | LP390572-8 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| EXAMPLE_UNITS | arb U/mL | |
| EXAMPLE_UCUM_UNITS | [arb'U]/mL |
| LONG_COMMON_NAME | en-US | Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay |
| LONG_COMMON_NAME | en-US | Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay |
| SHORTNAME | en-US | Certolizumab Ab SerPl IA-aCnc |
| ConsumerName | en-US | Certolizumab antibody, Blood |
| LONG_COMMON_NAME | fr-FR | Certolizumab anticorps [Arbitraire/Volume] Sérum/Plasma ; Numérique ; Immunoanalyse |
| LONG_COMMON_NAME | nl-NL | Certolizumab As [eenheid/volume] in serum of plasma d.m.v. immunoassay |
| LONG_COMMON_NAME | es-MX | Certolizumab Ab: Suero o Plasma : Punto temporal: Concentración arbitraria: Cuantitativo: Inmunoensayo |
LOINC Version: 2.77
FHIR